CLINICAL EFFICACY AND SAFETY OF AND A-2 ANTAGONIST EPROSARTAN IN PATIENTS WITH MILD AND MODERATE HYPERTENSION. RESULTS OF A MULTICENTER TRIAL
Clinical efficacy and safety of and A-2 antagonist eprosartan in patients with mild and moderate hypertension. Results of a multicenter trial.
Main Authors: | L. I. Olbinskaya, T. B. Andrushicina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2001-06-01
|
Series: | Российский кардиологический журнал |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2131 |
Similar Items
-
Angiotensin receptor-1 antagonist eprosartan in patients with mild to moderate arterial hypertension
by: A. V. Shabalin, et al.
Published: (2005-12-01) -
Clinical effectiveness of eprosartan and hydroxyzine in patients with mild to moderate arterial hypertension and coexisting anxiety
by: G. V. Pogosova, et al.
Published: (2009-02-01) -
EFFICACY AND SAFETY OF EPROSARTAN THERAPY AS ASSESSED FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE
by: A. L. Vertkin, et al.
Published: (2001-08-01) -
Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.
by: Pirttilä, T, et al.
Published: (2004) -
EFFICACY AND SAFETY OF ALBAREL IN PATIENTS WITH MILD, MODERATE AND SEVERE HYPERTENSION
by: N. N. Borovkov, et al.
Published: (2003-08-01)